Filter posts

ICYMI: Patent Abuse Is Undermining American Health Care

The pharmaceutical company Allergan recently announced a decision to transfer the intellectual property rights of …

Good Public Policy Key to Stable Biotech Investment Climate

It is an important and exciting time for the biotechnology industry. Science is galloping forward …

WSJ: U.S. Concessions on TPP Means Fewer Cures

Today’s Wall Street Journal editorial, Pacific Trade Brinksmanship, does an outstanding job highlighting the important …

Producing "21st Century Cures" - 2015 U.S. Legislative Outlook with Chairman Upton and Rep. DeGette

BIO President & CEO Jim Greenwood today sat down with Energy & Commerce Committee Chairman …

Greenwood Highlights Need for Bold Action to Address Alzheimer's

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and …

DuPont’s CEO receives George Washington Carver Award at BIO World Congress

Yesterday, Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, presented Ellen Kullman, …

BIO CEO Lays out Vision for Future of Industrial Biotech

During the opening plenary lunch at BIO’s World Congress on Industrial Biotechnology, Jim Greenwood, President …

Cohen, Boyer & Tibbetts?

Ask any biotech professional about Stanley Cohen and Herbert Boyer and they will tell you …

BIO President & CEO Presents Dr. Cohen With Lifetime Achievement Award

Last week, Jim Greenwood, President & CEO of the Biotechnology Industry Organization (BIO), attended the …

A Manhattan Project for Alzheimer's Disease

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & …